In “Doctored,” Charles Piller uncovers evidence that many important Alzheimer’s studies are based on faulty data.

Take two at bedtime. That’s what the label on the side of the bottle says, and that’s what you’ll do. You want to feel better soon — your health and well-being are important — so you’ll do as you’re ...

On SAVA's fourth-quarter 2024 earnings call, investors can expect updates regarding the company's pipeline developmental plans amid recent setbacks.

Doctored: Fraud, Arrogance, and Tragedy in the Quest to Cure Alzheimer’s” by Charles Piller Will this affect your life? How?

Explore the incredible process of harvesting millions of tons of cassava using modern farming techniques. See how advanced machinery, improved irrigation, and innovative methods help farmers ...

A research team led by Prof. An Zhisheng and Prof. Zhou Weijian from the Institute of Earth Environment of the Chinese Academy of Sciences (CAS) developed an innovative approach to examining the ...

A class action lawsuit was filed against Cassava Sciences Inc. (SAVA) by Levi & Korsinsky on December 12, 2024. The plaintiffs ...

Cassava Sciences, a Texas biopharma company, had developed simufilam to treat (and possibly cure) Alzheimer’s disease, the most common form of dementia that afflicts tens of millions of people ...

Foti, Jr., remind investors that they have until February 10, 2025 to file lead plaintiff applications in a securities class action lawsuit against Cassava Sciences, Inc. (NasdaqCM: SAVA), if they ...

NEW YORK, NY / ACCESS Newswire / February 6, 2025 / If you suffered a loss on your Cassava Sciences, Inc. (NASDAQ:SAVA) investment and want to learn about a potential recovery under the federal ...